Zipsor
Total Payments
$46,705
Transactions
3,313
Doctors
1,776
Companies
4
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $23,791 | 1,732 | 990 |
| 2018 | $22,505 | 1,548 | 1,035 |
| 2017 | $408.71 | 33 | 21 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $46,662 | 3,311 | 99.9% |
| Education | $43.38 | 2 | 0.1% |
Ad
Manufacturing Companies
- ASSERTIO THERAPEUTICS, Inc. $23,791
- Assertio Therapeutics, Inc. $21,264
- ASSERTIO THERAPEUTICS, INC. $1,241
- Depomed, Inc. $408.71
Product Information
- Type Drug
- Total Payments $46,705
- Total Doctors 1,776
- Transactions 3,313
About Zipsor
Zipsor is a drug associated with $46,705 in payments to 1,776 healthcare providers, recorded across 3,313 transactions in the CMS Open Payments database. The primary manufacturer is Assertio Therapeutics, Inc..
Payment data is available from 2017 to 2019. In 2019, $23,791 was paid across 1,732 transactions to 990 doctors.
The most common payment nature for Zipsor is "Food and Beverage" ($46,662, 99.9% of total).